Company: JUNS
Filing Date: 2025-10-27
Form Type: 8-K
Source: 0001493152-25-019783
Chunk: 8

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-10-27
Form: 8-K
Item: Item 1.01
Chunk 8
---
 Company effecting or
entering into an agreement to effect an “equity line of credit” or other substantially similar continuous offering with a
third party, in which the Company may offer, issue or sell Common Stock or any securities exercisable, exchangeable or convertible into
Common Stock at a future determined price. Furthermore, under the terms of the SEPA, until all outstanding amounts under the Promissory
Notes issued under the SEPA have been repaid in full, the Company may not repay any loans to any executives or employees of the Company
or make any payments in respect of any related party debt, including outstanding and accrued salaries, except that the Company is permitted
to pay (i) an amount equal to one-half of 2022-2024 outstanding bonuses to its executives as of October 24, 2025 (collectively, the “ Bonus”)
after disbursement of the first Pre-Paid Advance to the Company on October 27, 2025 and (ii) an amount equal to one-half of the Bonus
after disbursement of the second Pre-Paid Advance to the Company at the time referred to above. Furthermore, Yorkville has agreed that
during the term of the SEPA, none of Yorkville, any of its officers, or any entity managed or controlled by Yorkville, will enter into
or effect, directly or indirectly, either for Yorkville’s own principal account or for the principal account of any such entity
managed or controlled by Yorkville, any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the
Common Stock or any hedging transaction, which establishes a net short position with respect to the Common Stock.

As
consideration for Yorkville’s commitment to purchase Common Stock at the Company’s direction pursuant the SEPA,
the Company (i) paid to Yorkville a cash “structuring fee” in the amount of $25,000 and (ii) upon
execution of the SEPA, issued to Yorkville 131,909 shares of Common Stock (the “ Commitment Shares”), which Commitment Shares
have a total aggregate dollar value equal to $200,000, or 1.0% of Yorkville’s $20.0 million aggregate purchase commitment under
the SEPA (each Commitment Share valued at approximately $1.5162 per share, representing the VWAP on October 23, 2025, the
trading day immediately prior to the date of execution of